This image provided by Regeneron on Wednesday, Oct. 14, 2020 shows a vial of the company's Inmazeb medication. On Wednesday, the U.S. Food and Drug Administration said it has approved the drug for treating Ebola in both adults and children. (Regeneron via AP)
Featured Photo Galleries
